Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NG-350a by Akamis Bio for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
NG-350a is under clinical development by Akamis Bio and currently in Phase I for Metastatic Adenocarcinoma of The Pancreas. According...